Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Diarrhea × Theophylline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Prostatic Neoplasms 1 Lung Neoplasms 1 Diarrhea 1

Interventions

Irinotecan 3 Theophylline 1 Temozolomide 1 Oxaliplatin 1 Loperamide 1 Leucovorin 1 Fluorouracil 1 Fecal Microbiota Transplantation 1 Erlotinib Hydrochloride 1 Celecoxib 1 Cefpodoxime 1 Cefixime 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02080078 2019-05-03

A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline

AHS Cancer Control Alberta

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Diarrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡